×
Back to Agenda
Part 2.1: Industry Perspectives on EU HTA Regulation: Preparing for a Changing Landscape
Session Chair(s)
Ansgar Hebborn, PhD, MBA
Head - Access Policy Affairs Europe
F. Hoffmann-La Roche AG, Switzerland
Part 2.1: Round Table Discussions
- Challenges in the PICO process
- Working with the country access teams and franchise teams
- Ensuring readiness of the other functional areas that are impacted (regulatory, medical, pricing, patient engagement, policy, etc.)
- Overall capacity challenges in the system (at industry and agency level)
Have an account?